Value Line, Inc. Announces a 5.88% Increase in Its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
93
Value Line, Inc. Announces a 5.88% Increase in Its Quarterly Cash Dividend to $0.18 Per Common Share and Reaffirms Share Buyback Program

NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- Value Line, Inc., (NASDAQ: VALU ) announced that its Board of Directors declared on April 21, 2017 a quarterly cash dividend of $0.18 per common share, payable on May 11, 2017, to stockholders of record on May 2, 2017.  The Company has 9,712,145 shares of common stock outstanding as of April 21, 2017.

The Board of Directors also reaffirmed the Stock Repurchase Program of up to an aggregate of $3 million of Value Line, Inc.’s common stock adopted on September 19, 2012, with $617,000 remaining under the program.

Value Line, Inc. is a leading New York based provider of investment research. The Value Line Investment Survey is one of the most widely used sources of independent equity investment research.  Value Line also publishes a range of proprietary investment research in both print and digital formats including research in the areas of Mutual Funds, Options and Convertible securities.  Value Line’s acclaimed research also enables the Company to provide specialized products such as Value Line Select, Value Line Special Situations, Value Line Select: Dividend Income & Growth, and copyright data , distributed under copyright agreements for fees, including certain proprietary ranking system information and other proprietary information used in third party products.  Investment Management services are provided through its substantial non-controlling and non-voting interests in EULAV Asset Management, the investment advisor to The Value Line Family of Mutual Funds. Value Line’s products are available to individual investors by mail, at www.valueline.com or through 1-800-VALUELINE or 1-800-535-9648, while institutional-level services for professional investors, advisers, corporate, academic, municipal and legal libraries are offered at www.ValueLinePro.com , www.ValueLineLibrary.com and at 1-800-531-1425. 

Cautionary Statement Regarding Forward-Looking Information

This report contains statements that are predictive in nature, depend upon or refer to future events or conditions (including certain projections and business trends) accompanied by such phrases as “believe”, “estimate”, “expect”, “anticipate”, “will”, “intend” and other similar or negative expressions, that are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, as amended.  Actual results for Value Line, Inc. (“Value Line” or “the Company”) may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to the following:

  • maintaining revenue from subscriptions for the Company’s digital and print published products;
  • changes in market and economic conditions, including global financial issues;
  • protection of intellectual property rights;
  • dependence on non-voting revenues and non-voting profits interests in EULAV Asset Management, a Delaware statutory trust (“EAM” or “EAM Trust”), which serves as the investment advisor to the Value Line Funds and engages in related distribution, marketing and administrative services;
  • fluctuations in EAM’s assets under management due to broadly based changes in the values of equity and debt securities, redemptions by investors and other factors, and the effect these changes may have on the valuation of EAM’s intangible assets;
  • dependence on key personnel;
  • competition in the fields of publishing, copyright data and investment management;
  • the impact of government regulation on the Company’s and EAM’s businesses;
  • availability of free or low cost investment data through discount brokers or generally over the internet;
  • terrorist attacks, cyber attacks and natural disasters;
  • other risks and uncertainties, including but not limited to the risks described in Item 1A, “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended April 30, 2016; and in Part II, Item 1A of the Quarterly Report on Form 10-Q for the period ended January 31, 2017; and
  • other risks and uncertainties arising from time to time.

These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors which may involve external factors over which we may have no control or changes in our plans, strategies, objectives, expectations or intentions, which may happen at any time at our discretion, could also have material adverse effects on future results. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the SEC pursuant to the SEC's rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, current plans, anticipated actions, and future financial conditions and results may differ from those expressed in any forward-looking information contained herein.

Contact: Howard A. Brecher                                                                                                             Value Line, Inc. (212) 907-1500                                                                                    www.valueline.com www.ValueLinePro.com , www.ValueLineLibrary.com Facebook | Google+ | LinkedIn | Twitter Complimentary Value Line® Reports on Dow 30 Stocks

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 6

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 4

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Retirement Security Faces Global Headwinds in 2026

Updated Category News Views 10

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 5

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 4

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 5

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
BeyondCPG Accelerator Launches Seventh Growth Program

Updated Category News Views 4

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 5

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 5

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading

Top 5 Most Recently Viewed Articles

Nano Hearing Aids' CEO Global Tour: Strengthening Connections Worldwide

Updated Category News Views 58

Nano Hearing Aids' Global Strategy: A Tour to Remember Nano Hearing Aids is taking significant strides in expanding its presence worldwide. As part of this vision, Ryan F. Zackon, the esteemed CEO, is setting out on an ambitious global tour. This initiative aims to deepen partnerships and solidify relationships within the hearing aid community. Tour Objectives: Fostering...

Continue Reading
Toll Brothers Stock: A Look at 15 Years of Growth

Updated Category News Views 141

The Impressive Journey of Toll Brothers Stock Toll Brothers (NYSE: TOL) has demonstrated remarkable resilience and growth over the past 15 years. With an average annual return of 14.07%, it has outperformed the market by 1.87%. As of now, the company's market capitalization stands at an impressive $12.22 billion. Investment Potential: What If You Bought $1,000? Imagine...

Continue Reading
DigiKey Showcases Automation Innovations at SPS 2025 Event

Updated Category News Views 198

DigiKey to Showcase Automation Innovations at SPS 2025 Global distributor highlights extensive range of industrial automation products available in Europe THIEF RIVER FALLS, Minn. — DigiKey, a renowned global distributor of electronic components and automation solutions, invites attendees of the Smart Production Solutions (SPS) conference to visit its booth, #106 in...

Continue Reading
Cocrystal Pharma Advances CDI-988 in Phase 1 Clinical Trials

Updated Category News Views 120

Exciting Progress for CDI-988 in Clinical Trials Cocrystal Pharma, Inc. (NASDAQ: COCP) recently shared encouraging findings from its Phase 1 study of CDI-988, an innovative pan-viral inhibitor, during the Military Health System Research Symposium. This multi-day event focused on advancing military medical care, with Cocrystal presenting influential data that showcases the...

Continue Reading
Increased Support for Nova Minerals' Estelle Project Advancements

Updated Category News Views 153

Introduction to the Estelle Project Nova Minerals Limited (NASDAQ: NVA) has recently reported significant support for its Estelle Gold and Critical Minerals Project from Alaska State government officials and representatives from the Australian Consulate. These interactions highlight the growing recognition of the Estelle Project as crucial for the development of both...

Continue Reading